A non-invasive approach for Type 2 Diabetes and Hypertension risk evaluation in at-risk patients.

Aarca Research India Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Age greater than 30 years with one or more of the following risk factors:
•BMI > 25 kg/mÂ²
•Elevated waist circumference, > 35 inches for women and > 40 inches for men
•Habitually physically inactive (does not exercise regularly)
•Has delivered a baby weighing > 4kg or diagnosed with gestational diabetes
•Hypertension (>=130/>= 85 mmHg) or being treated for hypertension
•HDL cholesterol level < 35 mg/dL and/or a fasting triglyceride level >= 250 mg/dL or being treated for dyslipidemia with medication
•Has insulin resistance which can be identified using HOMMA-IR modelling
•Has been previously diagnosed with Polycystic Ovary Syndrome (PCOS)
•Had impaired glucose tolerance or impaired fasting glucose on previous testing within the last three years

•Under 25 years of age
•Receiving investigational treatments in the past 14 days
•Psychosocial issues that interfere with an ability to follow study procedures
•Current chemotherapy, or chemotherapy within the past 12 months
•Receiving medications that fluoresce
•Known to have, or at risk for, photosensitivity reactions ( e.g., sensitive to ultraviolet light, or taking medication known to cause photosensitivity)

发起方

Aarca Research India Pvt Ltd